Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed LaboratoryCybin Corp. Is A Best In Class Psychedelics Company When Compared To Industry Bellwether Compass PathwaysMindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial AdvisorMind Medicine Inc. Launches First Of Its Kind Clinical Trials Using Synergistic Psychedelic CompoundsNuminus Wellness Is Building A World Class Psychedelic Research OrganizationHAVN Life Sciences Is Off To A Great Start Out Of The GateMydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related AssetsNuminus Announces Closing of Oversubscribed $4.6 Million OfferingRritual™ Announces Suite of Premium Functional Mushroom and Adaptogenic ElixirsCEO Spotlight: Doug Drysdale of Cybin Corp.Aion Therapeutic, Inc. Announces the Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and ChAWAKN Life Sciences Launches Clinical Research Division with Prof. David Nutt & Dr. Ben Sessa Identifying Suitable Apotheca Systems Reveals AI Platform for Psychedelic Assisted PsychotherapyPsychedelics Company Havn Life Announces Commencement of Public Trading on the CSEAion Therapeutic Files Five Patents with the United States Patent and Trademark OfficeCybin Corp Announces Doug Drysdale as Chief Executive OfficerCompass Pathways Is Set To Take Psychedelics Mainstream With An IPO On The NasdaqNuminus Files Restated Financial ReportsMydecine Innovations Group Has Put Together A World Class Organization From A Human Capital PerspectiveMindMed Announces First-Ever Clinical Trial Combining MDMA and LSD

Join the top platform for cannabis stock analysis.

Premium Newsletter & Content Feed

A daily stream of market moving news, company announcements and earnings announcements keeps your finger on the pulse of the market.

Priority Access to Our Analysts

Have an urgent question on a stock, company, or trade? As a premium member, you have direct, priority access to our team.

Member’s Dashboard

Everything you need in one convenient, sleek dashboard. Access your premium news, market data, exclusive Mushroomstocks reports, and more.

What Members are Saying:

  • “In the crazy world of cannabis stocks, I’ve found Techincal420’s advice knowledge and invaluable. Techincal420’s team does a great job researching companies which helps me concentrate on the right companies. ” PAUL
  • “I read about technical 420 a couple months ago on a CNBC article… I was thrilled about Michael Berger’s idea of covering this seed-stage market since day one. Personally, I think the article undersold the value that Michael provides his subscribers. Michael is able to find value in an opaque market and rely that information in a way that is easy to understand and act on. If you want to invest in cannabis stocks, Mushroomstocks is the place to go!” ERALDO
  • “I want to thank Michael Berger for creating this resource. Similarly, I asked my Raymond James investment advisor about resources for investing in the Cannabis industry. I was given this website, among others. Out of all the resources I was given, Mushroomstocks without a doubt provides the most thorough and non-biased information on marijuana stocks and the cannabis industry. ” KAI
  • “Michael is a wiz when it comes to the stock market. I came to Mushroomstocks without any investment experience and Michael essentially tutored me and explained how everything works and why it works in the fashion it does. When it comes to the marijuana industry there is no one better. His cutting edge approach to this promising, yet opaque market is second to none. I would unquestionably recommend him to anyone who wants to learn about the marijuana stock industry.” NIMZJAB

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link